MORE►
UT Southwestern Medical Center
Three UT Southwestern researchers, from left, Dr. J. William Harbour, Elizabeth Chen and Yi Liu, received new grants for their work. [Photos: TAMEST]
Lyda Hill Philanthropies, TAMEST Award $1M More to Six Texas Researchers
by Sandra Engelland | Aug 27, 2026
Grants of $100,000 or $200,000 went to research projects not chosen for the 2026 Hill Prizes. Six Texas researchers, including three from Dallas’ UT Southwestern Medical Center, shared the $1 million.
by Sandra Engelland |
Apr 30, 2026
Participants at the Pegasus Park event had 48 hours to turn early-stage concepts and functional prototypes into actionable solutions "to improve health outcomes, expand access, improve patient experience, and drive system-wide efficiency," Health Wildcatters said.
MORE►
by Sandra Engelland |
Apr 1, 2026
A tower under construction at the new Moody Children’s Hospital in Dallas will be named Stephens Greth Tower in recognition of the gift, which is the fourth nine-figure gift given to the hospital project to date.
MORE►
by Maddie Preston |
Jan 13, 2026
The project, known as Vascularized Immunocompetent Tissue as an Alternative Liver, or VITAL, aims to "biofabricate" functioning livers using patients' own cells and advanced 3D printing techniques.
MORE►
The principal investigators at UT Southwestern Medical Center involved in the Specialized Program of Research Excellence (SPORE) for liver cancer are (from left) Hao Zhu, M.D.; Amit Singal, M.D., M.S.; David Hsieh, M.D.; Yujin Hoshida, M.D., Ph.D.; Adam Yopp, M.D.; and Daolin Tang, M.D., Ph.D. [Photo: UTSW]
UT Southwestern Wins $12M NCI ‘SPORE’ for Liver Cancer
by Lance Murray | Sep 18, 2025
UT Southwestern in Dallas will lead three liver cancer projects on prevention, recurrence, and immunotherapy. It joins Mayo Clinic and MD Anderson as a national NCI SPORE site, a program that moves discoveries into clinical trials.
MORE►
by Lance Murray |
Sep 11, 2025
The discovery reveals why people may be more susceptible to infections at certain times of day—and could open new paths for cancer immunotherapy and infection treatments.
MORE►
by Lance Murray |
Sep 9, 2025
Eric Olson has spent decades dedicated to what he calls “the biggest prize of all”: a cure for the devastating disease. Nearly half of the scientists awarded Columbia’s Horwitz Prize over the past 58 years went on to win a Nobel, UTSW said.
MORE►
by David Seeley |
Aug 19, 2025
Part of the 2025 iC³ Life Science & Healthcare Innovation Summit to be held September 16-17 in Dallas, the showcase pitch event is designed to connect university researchers with potential investors, industry executives, and strategic partners. This is the first year the showcase has expanded beyond Texas.
MORE►
[Image: Alena Butusava/istockphoto]
$3.1 Million NIH Grant Backs UTA Team’s AI Push in Antibody Drug Discovery
by Maddie Preston | Aug 8, 2025
The funding supports UT Arlington researcher Junzhou Huang, whose team recently ranked first in protein contact prediction and placed sixth overall in an international AI challenge competing against Google DeepMind, the University of Washington, and others.
MORE►
by Lance Murray |
Jul 24, 2025
Using a new tool developed at UT Southwestern Medical Center, researchers identified a gene that seems to be key in regulating food intake, offering a different pathway for potential obesity treatments.
MORE►
by Lance Murray |
Jun 16, 2025
The protein—implicated in blood cancers like leukemia, lymphoma, and multiple myeloma—was decoded in near-atomic detail by UT Southwestern researchers, including Nobel Prize winner Bruce Beutler. In lab models, turning off midnolin wiped out up to 92% of cancer cells—with minimal impact on healthy ones, according to UT Southwestern.
MORE►
by Lance Murray |
Jun 5, 2025
Co-founded by Chief Scientific Advisor Daniel J. Siegwart of UT Southwestern and CEO RA Session II, Signify Bio said it harnesses the human body for the production of in situ protein therapeutics. The round was led by Actium Group with participation from the Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, Eli Lilly and Company, and BrightEdge, the American Cancer Society's VC arm.
MORE►
Rendering of Children’s Health and UT Southwestern's planned new $5 billion pediatric health campus [Image: Children’s Health]
Moody Foundation Gives ‘Historic’ 9‑Figure Gift to Support New $5B Pediatric Hospital Campus in Dallas
by Lance Murray | May 6, 2025
To recognize the foundation's "record-breaking" support, the hospital at the new Dallas pediatric campus will be named Moody Children's Hospital upon completion in 2031.
MORE►
by Lance Murray |
May 2, 2025
A UT Southwestern study of blind fruit flies and mice reveals a brain-wide stress response, shedding light on the biological link between sensory loss and dementia.
MORE►
by Glenn Hunter |
Apr 30, 2025
Dallas Innovates, in partnership with the Dallas Regional Chamber, once again is recognizing the most innovative leaders in AI in Dallas-Fort Worth. From visionaries and mavericks to transformers and academics, AI 75's class of 2025 are the AI pacesetters you need to know now.
MORE►
by Quincy Preston |
Apr 24, 2025
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
MORE►
